PharmChem, Inc. (PCHM)
OTCMKTS
· Delayed Price · Currency is USD
3.000
0.00 (0.00%)
At close: Apr 25, 2025
PharmChem Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2003 | FY 2002 | FY 2001 | FY 2000 | FY 1999 | 1994 - 1998 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '04 Mar 31, 2004 | Dec '03 Dec 31, 2003 | Dec '02 Dec 31, 2002 | Dec '01 Dec 31, 2001 | Dec '00 Dec 31, 2000 | Dec '99 Dec 31, 1999 | 1994 - 1998 |
| Revenue | 25.73 | 26.46 | 30.09 | 36.57 | 39.39 | 44.49 | Upgrade
|
| Revenue Growth (YoY) | -11.12% | -12.07% | -17.72% | -7.18% | -11.45% | 3.05% | Upgrade
|
| Cost of Revenue | 19.98 | 20.59 | 23.01 | 32.53 | 28.97 | 31.37 | Upgrade
|
| Gross Profit | 5.74 | 5.86 | 7.07 | 4.04 | 10.43 | 13.11 | Upgrade
|
| Selling, General & Admin | 7.28 | 7.44 | 7.74 | 11.83 | 9.71 | 10.03 | Upgrade
|
| Operating Expenses | 7.28 | 7.44 | 7.86 | 12.13 | 9.63 | 10.36 | Upgrade
|
| Operating Income | -1.53 | -1.58 | -0.78 | -8.1 | 0.8 | 2.75 | Upgrade
|
| Interest Expense | -0.42 | -0.5 | -0.65 | -0.46 | -0.28 | -0.28 | Upgrade
|
| Interest & Investment Income | - | - | 0.14 | 0 | 0.01 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -0.01 | -0.07 | 0.02 | 0.03 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | -1.98 | -2.08 | -1.36 | -8.53 | 0.56 | 2.51 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -1.03 | - | - | Upgrade
|
| Impairment of Goodwill | -0.73 | -0.73 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.67 | 0.67 | - | - | - | - | Upgrade
|
| Pretax Income | -2.04 | -2.15 | -1.36 | -9.56 | 0.56 | 2.51 | Upgrade
|
| Income Tax Expense | - | - | -0.07 | -0.09 | 0.26 | -0.29 | Upgrade
|
| Earnings From Continuing Operations | -2.04 | -2.15 | -1.29 | -9.48 | 0.29 | 2.8 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 4.64 | 1 | 1.07 | - | Upgrade
|
| Net Income | -2.04 | -2.15 | 3.34 | -8.48 | 1.36 | 2.8 | Upgrade
|
| Net Income to Common | -2.04 | -2.15 | 3.34 | -8.48 | 1.36 | 2.8 | Upgrade
|
| Net Income Growth | - | - | - | - | -51.39% | 340.94% | Upgrade
|
| Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 6 | Upgrade
|
| Shares Change (YoY) | - | - | 0.03% | -3.59% | 1.93% | -4.55% | Upgrade
|
| EPS (Basic) | -0.35 | -0.37 | 0.57 | -1.45 | 0.23 | 0.48 | Upgrade
|
| EPS (Diluted) | -0.35 | -0.37 | 0.57 | -1.45 | 0.23 | 0.47 | Upgrade
|
| EPS Growth | - | - | - | - | -51.95% | 370.00% | Upgrade
|
| Free Cash Flow | - | - | -0.08 | -8.88 | 0.21 | 0.43 | Upgrade
|
| Free Cash Flow Per Share | - | - | -0.01 | -1.52 | 0.03 | 0.07 | Upgrade
|
| Gross Margin | 22.32% | 22.16% | 23.51% | 11.04% | 26.46% | 29.48% | Upgrade
|
| Operating Margin | -5.96% | -5.96% | -2.60% | -22.15% | 2.02% | 6.19% | Upgrade
|
| Profit Margin | -7.94% | -8.12% | 11.11% | -23.18% | 3.45% | 6.29% | Upgrade
|
| Free Cash Flow Margin | - | - | -0.26% | -24.29% | 0.52% | 0.97% | Upgrade
|
| EBITDA | - | 0.52 | 1.47 | -6.07 | 2.75 | 4.81 | Upgrade
|
| EBITDA Margin | - | 1.98% | 4.88% | -16.60% | 6.99% | 10.81% | Upgrade
|
| D&A For EBITDA | - | 2.1 | 2.25 | 2.03 | 1.96 | 2.06 | Upgrade
|
| EBIT | -1.53 | -1.58 | -0.78 | -8.1 | 0.8 | 2.75 | Upgrade
|
| EBIT Margin | -5.96% | -5.96% | -2.60% | -22.15% | 2.02% | 6.19% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 47.31% | - | Upgrade
|
Updated May 14, 2004. Source: S&P Global Market Intelligence. Standard template. Financial Sources.